Results 191 to 200 of about 52,122 (312)

Factors associated with changes in opioid analgesic prescribing after opioid agonist treatment initiation: A nationwide registry cohort study. [PDF]

Drug Alcohol Depend Rep
Rolova G, Skurtveit S, Bukten A, Odsbu I, Eide D.   +4 more
europepmc   +1 more source

Supporting Breastfeeding in the Setting of Perinatal Opioid Use Disorder

Journal of Midwifery &Women's Health, EarlyView.
Abstract Studies have shown that many pregnant women with opioid use disorder intend to initiate breastfeeding after giving birth. However, continuation rates beyond the initial postpartum hospitalization are low. Achieving and maintaining an antepartum breastfeeding plan may be complicated by the unique challenges that opioid‐exposed dyads experience ...
Lindsey A. Baksh, Stephanie M. Hartwig
wiley   +1 more source

Association between the location of Opioid Agonist Treatment (OAT) providers and heroin-related ambulance attendances. [PDF]

Subst Abuse Treat Prev Policy
Hall N, Rowland B, Ogeil RP, Loos R, Nehme Z, Lubman DI.   +5 more
europepmc   +1 more source

Pre‐anaesthetic risk assessment and management of dogs with myxomatous mitral valve disease: a spectrum of care narrative review

Journal of Small Animal Practice, EarlyView.
Myxomatous mitral valve disease, an acquired valvular degeneration, is the most common cardiac disorder in dogs, affecting approximately 10% of dogs in primary care veterinary practice. Dogs with myxomatous mitral valve disease frequently require anaesthesia for routine procedures.
I. Levinzon, L. Köster, E. Vettorato, A. H. Estrada   +3 more
wiley   +1 more source

Opioid agonist therapy.

Canadian family physician Medecin de famille canadien, 2017
Kathleen, Broad, Hector Ahmed, Colon-Rivera, Lamia, Haque   +2 more
openaire   +1 more source

Probation as a targeted entry point for scaling up opioid agonist therapies in Moldova using a modified screening, brief intervention and referral to treatment strategy. [PDF]

PLOS Glob Public Health
Ponticiello MN, Bromberg DJ, Azbel L, Cugut S, Doltu S, Altice FL.   +5 more
europepmc   +1 more source

Parasomnias and sleep‐related movement disorders induced by drugs in the adult population: a review about iatrogenic medication effects

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont, Vanessa Bloch, Agnès Lillo‐Lelouet, Christine Le Beller, Pierre A. Geoffroy, Marc Veyrier   +5 more
wiley   +1 more source

Community Pharmacy-Based Injectable Opioid Agonist Treatment: Findings From a Canadian Pilot Program. [PDF]

Drug Alcohol Rev
Mihic T, Socias ME, McCrae K, Johnson C, Nolan S, Grant C, Sutherland C, Fairbairn N.   +7 more
europepmc   +1 more source

Investigation of the “Not Better Explained” Diagnosis Criteria in Sleep Disorder Classifications: A Systematic Content Analysis and Critical Review

Journal of Sleep Research, EarlyView.
The “Not Better Explained” (NBE) criterion plays a key role in preventing diagnostic misclassification by structuring causal reasoning in sleep medicine. This systematic content analysis compares the use, wording, and excluded conditions of NBE criteria across the ICSD‐3‐TR and DSM‐5‐TR for ten major sleep disorders.
Jean‐Arthur Micoulaud‐Franchi, Vincent P. Martin, Julien Coelho, Régis Lopez, Pierre‐Alexis Geoffroy, Laure Peter‐Derex, Isabelle Lambert, Charles M. Morin, Clélia Quiles, Christophe Gauld   +9 more
wiley   +1 more source

POTENCY RATIO BETWEEN OPIOID AGONISTS AND PARTIAL AGONISTS

British Journal of Anaesthesia, 1987
openaire   +2 more sources